NCT05149417 is a NA clinical trial of SMS reminding in Post-traumatic Pain, sponsored by University of Monastir.

Who is sponsoring NCT05149417?

NCT05149417 is sponsored by University of Monastir.

What drugs are being tested in NCT05149417?

Interventions in NCT05149417: SMS reminding, telemonitoring.

What condition does NCT05149417 study?

NCT05149417 studies Post-traumatic Pain.

Is NCT05149417 still recruiting?

NCT05149417 is currently completed. Last updated 10 August 2022.

Last reviewed 2022-08-10 · How we verify

NCT05149417

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Telemedecine on Post -Trauma Pain Medication Adherence .

Completed NA Last updated 10 August 2022

What this trial tests

NA trial testing SMS reminding in Post-traumatic Pain in 1,350 participants. Completed in 31 July 2022.

Timeline

21 August 2020

Primary endpoint
21 May 2022

31 July 2022

Quick facts

Lead sponsor	University of Monastir
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	1,350
Start date	21 August 2020
Primary completion	21 May 2022
Estimated completion	31 July 2022
Sites	2 locations across Tunisia

Drugs / interventions tested

SMS reminding
telemonitoring

Conditions studied

Post-traumatic Pain — all drugs for Post-traumatic Pain →

Sponsor

University of Monastir

Who can join

Adults 16 to 90, any sex, with Post-traumatic Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The impact of telemonitoring on patients' adherence to post trauma pain treatment , their satisfaction and pain relief after discharge from the ED.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Monastir trials

Trials by the same sponsor.

NCT07345156 — Congestion and LActate at diScHarge in Acute Heart Failure · not yet recruiting
NCT07181642 — Diaphragmatic Breathing for Sleep Bruxism in Adults: A Randomized Controlled Trial · NA · completed
NCT06980727 — Comparative Efficacy of IV Dexamethasone vs. Nebulized Salbutamol for Renal Colic Pain in the ED · Phase 3 · not yet recruiting
NCT06900972 — Effect of Colloids Versus Crystalloids on Heart Mechanics: a Double-blind Cross Over Randomized Trial · Phase 3 · enrolling by invitation
NCT06723002 — Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome · Phase 2, PHASE3 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05149417 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Monastir
Last refreshed: 10 August 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05149417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing